ID
14610
Description
A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin; ODM derived from: https://clinicaltrials.gov/show/NCT00231660
Link
https://clinicaltrials.gov/show/NCT00231660
Keywords
Versions (1)
- 4/24/16 4/24/16 -
Uploaded on
April 24, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Obesity NCT00231660
Eligibility Obesity NCT00231660
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Contraindication or hypersensitivity to topiramate
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0076829
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C0076829
Description
Antidiabetic medications
Data type
boolean
Alias
- UMLS CUI [1]
- C0935929
Description
Weight loss
Data type
boolean
Alias
- UMLS CUI [1]
- C1262477
Description
Type 1 diabetes
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Hypoglycemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0020615
Description
Pulmonary disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0024115
Similar models
Eligibility Obesity NCT00231660
- StudyEvent: Eligibility
C0025598 (UMLS CUI [2])
C2348070 (UMLS CUI [1,2])
C0015787 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0032976 (UMLS CUI [4])
C0076829 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0076829 (UMLS CUI [2,2])